Evidence map›Paper›PMID 40729052›Full record

ReviewAsian Pacific journal of cancer prevention : APJCP2025

New Surgical Techniques for Early Stage Cervical Cancer Under 2 cm : Is There Enough Evidence?

Nasuh Utku Dogan, Selen Dogan

Abstract readReview
In one paragraph

Review in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nasuh Utku DoganPrivate DOGAN Gynecology Clinic, Antalya, Turkiye.
Selen DoganDepartment of Gynecologic Oncology, Akdeniz University, Faculty of Medicine, Antalya, Turkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimCervical cancer is the fourth most common malignancy in women worldwide and the second leading cause of cancer related mortality globally, making it a significant public health problem. Half of the women diagnosed are at an early stage; these women are typically young, mainly nulliparous, and have a long life expectancy. Less radical surgery is an attractive option for this selected group. In this narrative review, we aim to summarize the data regarding less radical surgery for early cervical cancer.

methodsStudies regarding less radical surgery including, conisation, simple trachelectomy and simple hysterectomy were searched in PUBMED database  in English and included from January 1995 to September 2024.Retrospective studies with a significant number of patients and  randomised controlled studies in this subject were included and discussed in detail as well.

resultsRetrospective studies have identified a low rate of parametrial involvement in specific subsets of patients with early cervical cancer, such as those with small tumor sizes (less than 2 cm), cervical stromal invasion less than 10 mm, no lymph node involvement, and no distant disease on imaging. In these patients, the incidence of parametrial involvement is less than 1%, which may render radical surgery unjustifiable. For this selected group, less radical surgery options, such as conization or simple hysterectomy, become attractive alternatives.

conclusionsWhen fertility preservation is desired, conization is an option; when fertility is not a concern, simple hysterectomy is the standard approach. Strict patient selection and preoperative evaluation are critical.

Indexed as

ConizationHysterectomyUterine Cervical NeoplasmsFemaleHumansNeoplasm StagingPrognosisTrachelectomyCervical cancerconisationRadical hysterectomysimple hysterectomytrachelectomy

Identifiers

PMID40729052
PMCPMC12507065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.